Log in to save to my catalogue

An amphiphilic dendrimer as a light-activable immunological adjuvant for in situ cancer vaccination

An amphiphilic dendrimer as a light-activable immunological adjuvant for in situ cancer vaccination

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_9406f8b05e734a97845b344a34803f0b

An amphiphilic dendrimer as a light-activable immunological adjuvant for in situ cancer vaccination

About this item

Full title

An amphiphilic dendrimer as a light-activable immunological adjuvant for in situ cancer vaccination

Publisher

London: Nature Publishing Group UK

Journal title

Nature communications, 2021-08, Vol.12 (1), p.4964-4964, Article 4964

Language

English

Formats

Publication information

Publisher

London: Nature Publishing Group UK

More information

Scope and Contents

Contents

Immunological adjuvants are essential for successful cancer vaccination. However, traditional adjuvants have some limitations, such as lack of controllability and induction of systemic toxicity, which restrict their broad application. Here, we present a light-activable immunological adjuvant (LIA), which is composed of a hypoxia-responsive amphiphi...

Alternative Titles

Full title

An amphiphilic dendrimer as a light-activable immunological adjuvant for in situ cancer vaccination

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_doaj_primary_oai_doaj_org_article_9406f8b05e734a97845b344a34803f0b

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_9406f8b05e734a97845b344a34803f0b

Other Identifiers

ISSN

2041-1723

E-ISSN

2041-1723

DOI

10.1038/s41467-021-25197-z

How to access this item